Detail
| LncRNA Name | nc886 |
| Synonyms | VTRNA2-1, CBL-3, CBL3, MIR886, MIRN886, VTRNA2, hvg-5, nc886, svtRNA2-1a |
| Region | GRCh38_5:136080470-136080597 Sequence |
| Ensembl | ENSG00000270123 |
| RefSeq | NR_030583 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✔ |
| Variant | ✘ |
| TF | ✔ |
| Methylation | ✔ |
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | RNA-seq, qPCR etc. |
| Sample | gastric cancer tissues, gastric cell lines |
| Expression Pattern | down-regulated |
| Function Description | Our real-time RT-PCR data (Fig 1A) indicated that the expression level of nc886 was lower in a subpopulation of tumor tissues than in normal tissues. nc886 inhibits cell proliferation when ectopically expressed in gastric cancer cells. |
| Pubmed ID | 25003254 |
| Year | 2014 |
| Title | nc886, a non-coding RNA of anti-proliferative role, is suppressed by CpG DNA methylation in human gastric cancer. |
| External Links |
| Links for nc886 | GenBank HGNC lncrnadb Noncode |
| Links for gastric cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.